PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22960624-2 2013 The currently used therapy, focusing on the reactivation of inhibited AChE, is limited to peripheral tissues because commonly used quaternary pyridinium oxime reactivators do not cross the blood brain barrier (BBB) at therapeutically relevant levels. quaternary pyridinium oxime 131-158 acetylcholinesterase (Cartwright blood group) Homo sapiens 70-74